君实生物

- 688180

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
君实生物(688180) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入38,080.43150,254.9998,645.7666,970.2725,515.45
营业收入38,080.43150,254.9998,645.7666,970.2725,515.45
二、营业总成本70,337.95381,185.95247,937.18177,281.4989,761.97
营业成本10,809.4254,097.6433,684.5025,215.568,551.25
营业税金及附加564.341,970.431,343.50877.60358.09
销售费用19,159.2984,435.5955,440.8537,312.6918,262.17
管理费用12,330.9653,643.9635,940.0223,230.4111,313.84
财务费用-155.26-6,708.62-5,534.36-4,214.65-1,489.36
研发费用27,629.21193,746.95127,062.6694,859.8852,765.99
资产减值损失----------
公允价值变动收益-115.47-14,917.74-4,584.82-2,776.62-612.48
投资收益-739.737,399.04-4,486.65-2,807.06-1,385.92
其中:对联营企业和合营企业的投资收益-733.52-6,048.47-4,910.10-3,230.52-1,562.57
汇兑收益----------
三、营业利润-29,283.56-245,744.24-158,036.27-116,229.20-63,321.83
加:营业外收入1.72391.33392.89361.180.45
减:营业外支出373.093,816.553,108.161,814.41424.01
其中:非流动资产处置损失----------
四、利润总额-29,654.94-249,169.46-160,751.54-117,682.43-63,745.39
减:所得税费用309.864,399.47-5,238.65-5,049.48216.61
五、净利润-29,964.80-253,568.93-155,512.89-112,632.95-63,961.99
归属于母公司所有者的净利润-28,302.91-228,343.19-140,681.84-99,741.24-54,343.23
少数股东损益-1,661.89-25,225.74-14,831.05-12,891.71-9,618.76
六、每股收益
基本每股收益(元/股)-0.2900-2.3200-1.4300-1.0100-0.5500
稀释每股收益(元/股)-0.2900-2.3200-1.4300-1.0100-0.5500
七、其他综合收益85.26-7,365.85-5,073.28-3,817.82-2,744.73
八、综合收益总额-29,879.54-260,934.78-160,586.17-116,450.77-66,706.72
归属于母公司所有者的综合收益总额-28,217.65-235,709.03-145,755.12-103,559.06-57,087.96
归属于少数股东的综合收益总额-1,661.89-25,225.74-14,831.05-12,891.71-9,618.76
下载全部历史数据到excel中 返回页顶